David Giarracco

About David Giarracco

As CEO of Noninvasix, I’m leading the commercialization of a breakthrough non-invasive…

Experience

1. Chief Executive Officer

   Noninvasix

   Nov 2021 — Present

   Recruited by the board to fulfill the promise of Noninvasix and be the first to non-invasively monitor the severity of sepsis and septic shock, enabling clinicians to diagnose and monitor the response to treatment of tissue hypoxia in real-time. Our patented optoacoustic platform technology is the first solution to non-invasively and continuously measure central venous saturation. Incorporating Noninvasix into the ICU workflow allows clinicians to more quickly and accurately diagnose their critically ill patients and tailor treatments to improve outcomes. Future developments, enhancements, and evidence will expand the use and clinical impact of our technology into other indications and settings.

Education

• The Johns Hopkins University School of Medicine

  Master of Arts - MA, Biomedical Engineering

• The Johns Hopkins University

  Bachelor of Science - BS, Biomedical Engineering & Materials Science

Skills

• Disposables
• Strategic Planning
• Biomedical Engineering
• Capital Equipment
• Urology
• Business Process Improvement
• Sales Management
• Sales Operations
• Product Launch
• Hospitals
• Surgeons
• Business Integration
• Cross-Functional Team Leadership
• Healthcare
• Strategy
• Business Development
• Manufacturing
• Surgical Instruments
• Market Research
• U.s. Food and Drug Administration (Fda)
• Market Development
• Key Opinion Leaders
• Operations Management
• Competitive Analysis
• Iso 13485
• Six Sigma
• Medical Devices
• Cardiology
• Product Management
• Leadership
• Operating Room
• Orthopedic
• Process Improvement
• Commercialization
• Team Building
• Surgery
• Fda
• Management
• Design Control
• Medical Imaging